How Arava Works: Mechanism of Action

The therapeutic efficacy of Arava in Rheumatoid Arthritis stems from its unique mechanism of action. When you take Arava, it is metabolized in the body to its active form, A77 1726 (teriflunomide). This active metabolite works by inhibiting dihydroorotate dehydrogenase (DHODH), a crucial enzyme involved in de novo pyrimidine synthesis. Pyrimidines are essential building blocks for DNA and RNA, vital for cell growth and division.

Lymphocytes, particularly activated T-cells, which are key players in the autoimmune processes of Rheumatoid Arthritis, rely heavily on de novo pyrimidine synthesis for their rapid proliferation. By inhibiting DHODH, Arava effectively starves these overactive immune cells of the necessary components for their growth, thereby limiting their expansion and reducing the inflammatory response. This antiproliferative effect on lymphocytes is central to Arava‘s ability to reduce inflammation, slow joint destruction, and alleviate the symptoms of Rheumatoid Arthritis.

Dosage and Administration of Arava

The dosage regimen for Arava (leflunomide) is tailored to the individual and often begins with a loading dose to achieve therapeutic levels more quickly, followed by a lower maintenance dose. Your healthcare provider will determine the most appropriate dosing schedule based on your specific condition and response to treatment.

• Loading Dose: Some patients may begin with a loading dose, typically 100 mg once daily for three days. This helps to rapidly reach steady-state plasma concentrations of the active metabolite. However, a loading dose is not always used, especially in patients who may be more susceptible to early side effects.
• Maintenance Dose: Following the loading dose, or as the initial treatment, the usual maintenance dose is 20 mg once daily. For patients who may not tolerate 20 mg daily, a reduced dose of 10 mg once daily may be considered.
• Administration: Arava tablets should be swallowed whole with water. They can be taken with or without food. Consistency in taking the medication at the same time each day can help maintain stable drug levels in your body.
• Duration of Treatment: Arava is a long-term treatment for Rheumatoid Arthritis. It may take several weeks to months to experience the full therapeutic benefits. It is crucial to continue taking Arava as directed by your healthcare provider, even if you start to feel better. Do not stop treatment without consulting your doctor, as this could lead to a flare-up of your RA symptoms.

Benefits of Arava in RA Management

Arava offers several significant benefits in the management of Rheumatoid Arthritis, making it a valuable option for many patients:

• Slowing Disease Progression: One of the most critical benefits of Arava is its ability to slow the progression of joint damage. Studies have shown that leflunomide can inhibit the erosions and narrowing of joint spaces that are characteristic of advanced RA, thereby preserving joint structure and function over time.
• Reducing Inflammation and Pain: By modulating the immune response, Arava helps to reduce the chronic inflammation that causes pain, swelling, and stiffness in the joints. Patients often report a significant reduction in joint tenderness and swelling.
• Improving Physical Function: With reduced pain and inflammation, patients experience improved mobility and the ability to perform daily activities more easily. This can lead to a substantial improvement in quality of life.
• Monotherapy or Combination Therapy: Arava can be used as a monotherapy or in combination with other DMARDs, including some biologic agents, depending on the severity of the disease and individual patient response. Your doctor will determine the best treatment strategy for you.

Potential Side Effects of Arava

Like all medications, Arava (leflunomide) can cause side effects. While many people tolerate Arava well, it’s important to be aware of the potential adverse effects and discuss any concerns with your healthcare provider. Close monitoring is essential during treatment.

• Liver Damage (Hepatotoxicity): Although rare, severe liver injury, including liver failure, can occur. Symptoms include persistent nausea/vomiting, dark urine, yellowing of the skin or eyes (jaundice), and unusual tiredness.
• Bone Marrow Suppression: Arava can suppress bone marrow function, leading to a decrease in white blood cells (increasing infection risk), red blood cells (anemia), and platelets (increasing bleeding risk). Regular complete blood counts (CBCs) are vital for monitoring.
• Serious Infections: Due to its immune-modulating effects, Arava can increase the risk of serious infections, including opportunistic infections. Report any signs of infection (fever, chills, sore throat, persistent cough) immediately.
• Interstitial Lung Disease (ILD): This is a rare but potentially severe complication characterized by inflammation and scarring of the lung tissue. Symptoms include new or worsening cough, shortness of breath, and fever.
• Peripheral Neuropathy: Numbness, tingling, or weakness in the hands or feet can occur, indicating nerve damage.
• Severe Skin Reactions: Rarely, severe skin reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis have been reported. Seek immediate medical help if you develop widespread rash, blistering, or peeling skin.

It is paramount to report any new or worsening symptoms to your healthcare provider promptly. Regular blood tests to monitor liver function and blood counts are essential throughout your treatment with Arava.

Prior to starting Arava (leflunomide), and regularly throughout treatment, your healthcare provider will assess your medical history and conduct various tests to ensure its safe use. Several factors influence the suitability and safe administration of this medication.

• Severe Liver Disease: Arava is contraindicated in patients with pre-existing severe liver disease, as it can cause significant hepatotoxicity. Careful monitoring of liver enzymes is required for all patients.
• Immunodeficiency and Bone Marrow Dysplasia: Patients with severe immunodeficiency or bone marrow hypoplasia, severe anemia, leukopenia, or thrombocytopenia of non-RA origin should not use Arava due to increased risk of serious infections or worsening blood disorders.
• Serious Active Infections: Treatment should not be initiated in patients with active, severe infections. If a serious infection develops during treatment, Arava may need to be temporarily discontinued.
• Tuberculosis Screening: Before starting Arava, patients should be screened for latent tuberculosis, as DMARDs can reactivate dormant infections.
• Renal Impairment: While mild to moderate renal impairment does not typically require a dose adjustment, patients with severe renal impairment should be treated with caution, as data in this population is limited.
• Vaccinations: Live attenuated vaccines should not be administered to patients receiving Arava due to the immunosuppressive effects of the drug. Inactivated vaccines may be less effective.

Arava can interact with other medications, potentially altering their effects or increasing the risk of side effects. Always inform your healthcare provider about all medications you are currently taking, including over-the-counter drugs, supplements, and herbal remedies.

• Methotrexate: Co-administration of Arava with methotrexate may increase the risk of liver toxicity and bone marrow suppression. Close monitoring is essential if these drugs are used together.
• Hepatotoxic Drugs: Concomitant use with other medications known to cause liver damage (e.g., acetaminophen in high doses, certain antibiotics) should be approached with caution.
• Cholestyramine and Activated Charcoal: These agents can significantly decrease plasma levels of Arava‘s active metabolite by accelerating its elimination. They are sometimes used in a “washout” procedure if rapid elimination of Arava is necessary (e.g., due to severe side effects or before a planned pregnancy).
• NSAIDs (Nonsteroidal Anti-Inflammatory Drugs): Arava can generally be used concomitantly with NSAIDs, which are often prescribed for symptom relief in RA.
• Warfarin: Arava may potentiate the effects of warfarin, increasing the risk of bleeding. If taken together, careful monitoring of INR (International Normalized Ratio) is advised.
• Other Immunosuppressants: Caution is advised when combining Arava with other immunosuppressive agents, as this can further increase the risk of infection.

While Arava is an effective treatment for many, specific considerations apply to certain patient groups:

• Elderly Patients: Older adults may be more susceptible to certain side effects, particularly gastrointestinal issues and liver enzyme elevations. Close monitoring is recommended.
• Patients with Hepatic Impairment: As Arava is extensively metabolized by the liver, it is contraindicated in severe hepatic impairment. For mild to moderate impairment, close monitoring of liver function is critical.

It is vital to have an open and ongoing dialogue with your healthcare provider about your medical history, any other conditions you have, and all medications you are taking. This ensures that Arava is used safely and effectively for your Rheumatoid Arthritis.

Table of Arava Characteristics

Frequently Asked Questions About Arava

Here are answers to some of the most common questions patients and caregivers have about Arava (leflunomide) for Rheumatoid Arthritis:

1. How long does it take for Arava to start working?

   Arava is a DMARD, meaning it works over time to modify the disease. You might start to notice some improvements in your symptoms within 4 to 6 weeks, but the full therapeutic benefits, such as significant reduction in joint pain, swelling, and stiffness, and slowing of disease progression, may take 3 to 6 months to become apparent. It’s important to be patient and continue taking your medication as prescribed, even if you don’t feel immediate relief.

2. Can Arava be taken with other RA medications?

   Yes, Arava is often used in combination with other Rheumatoid Arthritis medications. It can be combined with other conventional DMARDs (like hydroxychloroquine or sulfasalazine) or biologic DMARDs to achieve better disease control, especially in moderate to severe cases. However, combination with methotrexate requires careful monitoring due to an increased risk of side effects. Always discuss your full medication regimen with your healthcare provider to ensure safe and effective use.

3. What should I do if I miss a dose of Arava?

   If you miss a dose of Arava, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one. If you frequently miss doses, or are unsure, contact your healthcare provider for advice.

4. Are there any dietary restrictions while taking Arava?

   Generally, there are no specific dietary restrictions imposed while taking Arava. You can take it with or without food. However, it’s always a good idea to maintain a balanced diet for overall health. If you experience gastrointestinal side effects like diarrhea, your doctor might suggest dietary adjustments to manage those symptoms. It is also important to limit or avoid alcohol consumption while taking Arava due to the increased risk of liver problems.

5. How often will I need blood tests while on Arava?

   Regular monitoring is crucial when taking Arava. Your healthcare provider will typically order blood tests to check your liver function (ALT, AST) and complete blood counts (CBC) before starting treatment, and then periodically during treatment. This usually involves tests every month or two for the first six months, and then every 6-8 weeks, or as directed by your doctor. These tests help to detect potential serious side effects like liver damage or bone marrow suppression early.

6. What are the signs of liver problems I should watch for?

   While on Arava, it’s important to be vigilant for signs of liver problems. Contact your doctor immediately if you experience symptoms such as persistent nausea or vomiting, dark urine, yellowing of your skin or the whites of your eyes (jaundice), unusual tiredness or fatigue, pain in the upper right side of your abdomen, or loss of appetite.

7. Is Arava a cure for Rheumatoid Arthritis?

   No, Arava is not a cure for Rheumatoid Arthritis. RA is a chronic condition, and currently, there is no known cure. Arava is a disease-modifying treatment designed to manage the symptoms, slow the progression of joint damage, and improve your physical function and quality of life. It works to put the disease into remission or significantly reduce its activity.

8. Can I stop taking Arava if I feel better?

   You should never stop taking Arava or any other RA medication without first consulting your healthcare provider. Even if your symptoms have improved significantly, stopping Arava abruptly can lead to a flare-up of your Rheumatoid Arthritis symptoms and potentially worsen joint damage. Your doctor will advise you on the appropriate duration of treatment and how to adjust your medication if needed.

9. What if I need to stop Arava due to side effects or other reasons? How is it eliminated from the body?

   Arava‘s active metabolite has a very long half-life, meaning it stays in the body for an extended period after discontinuation. If there’s a need to rapidly eliminate the drug (e.g., due to severe side effects or before a planned medical procedure), a “washout” procedure can be performed. This typically involves administering cholestyramine (an anion exchange resin) or activated charcoal, which helps bind the active metabolite in the gut and accelerate its removal from the body. Your doctor will provide specific instructions if a washout procedure is necessary.

10. Can I get vaccinated while on Arava?

    It’s generally recommended to avoid live attenuated vaccines while taking Arava due to its immunosuppressive effects, which could lead to a less effective immune response or even an infection from the vaccine itself. Inactivated vaccines (like the flu shot or most COVID-19 vaccines) are generally considered safe, but your immune response to them might be diminished. Always discuss your vaccination plans with your healthcare provider to ensure safety and effectiveness.

Arava (leflunomide) stands as an essential medication in the comprehensive management of Rheumatoid Arthritis. By targeting the underlying disease process, it offers significant benefits in reducing inflammation, alleviating pain, improving physical function, and crucially, slowing the progression of joint damage. Understanding how Arava works, its proper administration, potential side effects, and important safety considerations is vital for optimizing your treatment.

While Arava can dramatically improve the lives of individuals with RA, it is a powerful medication that requires close collaboration with your healthcare provider. Regular monitoring, open communication about any symptoms or concerns, and adherence to your prescribed treatment plan are key to achieving the best possible outcomes in your journey with Rheumatoid Arthritis**.